학술논문

Prospective multicenter phase II study of irinotecan as third-line therapy in metastatic colorectal cancer and progression after bolus and infusional 5-fluorouracil
Document Type
Journal
Source
ANTI-CANCER DRUGS; JUN 2004, 15 5, p473-p477, 5p.
Subject
Language
English
ISSN
09594973